Plain-English translation of NCT06855810 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new treatment plan for children with T-cell acute lymphoblastic leukemia (T-ALL), a serious blood cancer. The study uses several medications including and alongside traditional chemotherapy drugs, tailored based on what type of T-ALL a child has and how well the cancer responds to early treatment. The goal is to improve survival rates while reducing long-term side effects on fertility.
Current treatments for childhood T-ALL work, but doctors want to make them better by using newer medications that target specific types of leukemia cells more precisely. This trial also aims to reduce the use of certain harsh chemotherapy drugs that can affect a young person's ability to have children in the future.
You likely qualify if…
You likely don't qualify if…
Your child would receive intensive chemotherapy in phases over several months to a few years, with hospital visits and outpatient appointments for treatment and monitoring. The specific medications and doses would be chosen based on your child's leukemia type and response to initial treatment. Blood tests and bone marrow samples would be taken regularly to track how well the treatment is working, and doctors may adjust the plan based on these results.
AI-generated summary from trial data · Jun 18, 2026 · Not medical advice
China